Trial of PRO1160 (GEN1160) in Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) (PRO1160-001)
Genmab
Genmab
Fate Therapeutics
Hoffmann-La Roche
City of Hope Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Arizona
Mirna Therapeutics, Inc.